# TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders

> **NCT07377032** · PHASE3 · RECRUITING · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 40 (estimated)

## Conditions studied

- GRIN-related Disorders
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2D
- Epilepsy
- Neurodevelopmental Disorder (Diagnosis)

## Interventions

- **DIETARY_SUPPLEMENT:** L-serine
- **OTHER:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07377032
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377032, "TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07377032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*